Related Experiment Videos
The Dual Roles of NRF2 in Cancer
Silvia Menegon1, Amedeo Columbano2, Silvia Giordano1
1University of Torino, Department of Oncology, Candiolo Cancer Institute-FPO, IRCCS, Strada Provinciale 142, 10060 Candiolo, Torino, Italy.
Abstract:
NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress. However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy. In a rapidly advancing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment.
Insights
Nuclear factor erythroid 2-related factor 2 (NRF2) traditionally viewed as a tumor suppressor, can promote cancer cell survival and resistance. This review explores NRF2
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- Nuclear factor erythroid 2-related factor 2 (NRF2) is recognized for its cytoprotective roles against cellular insults.
- Emerging evidence suggests NRF2 pathway hyperactivation promotes cancer cell survival and resistance to therapies.
- This dual role necessitates a deeper understanding of NRF2 in cancer progression.
Purpose of the Study:
- To review the oncogenic mechanisms driven by NRF2.
- To summarize the current landscape of NRF2 inhibitors.
- To establish the rationale for targeting NRF2 in cancer therapy.
Main Methods:
- Literature review of recent studies on NRF2 function in cancer.
- Analysis of NRF2 pathway activation and its consequences.
- Survey of existing and developing NRF2-targeting agents.
Main Results:
- NRF2 activation confers resistance to oxidative stress, chemotherapy, and radiotherapy.
- Specific oncogenic mechanisms of NRF2 are elucidated.
- Several NRF2 inhibitors are under investigation.
Conclusions:
- NRF2's role in cancer is complex, with significant oncogenic potential.
- NRF2 inhibitors represent a promising therapeutic strategy for cancer treatment.
- Targeting NRF2 offers a novel approach to combat cancer progression and therapy resistance.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Mitogens and the Cell Cycle
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Abnormal Proliferation